Skip to main content
Premium Trial:

Request an Annual Quote

Stratose to Cover CombiMatrix's Microarray Testing Services

NEW YORK (GenomeWeb News) – CombiMatrix said today that it has entered into an agreement with Stratose to provide coverage for its menu of diagnostic laboratory services, including its CombiSNP chromosomal microarray test.

Atlanta-based Stratose maintains a large preferred provider organization network in the US, including more than 850,000 direct and affiliate medical, dental, and workers' compensation provider contracts. Members of these plans will now have access to CombiMatrix's suite of tests for use in prenatal, miscarriage, and pediatric healthcare.

CombiMatrix has announced agreements with a number of organizations to expand access to its services this year. In March, it partnered with American Pathology Partners to offer its microarray-based miscarriage testing service, and in January, it contracted with Galaxy Health Network to provide coverage of its tests for Galaxy's 3.5 million covered lives.

The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.